NCT04211220View on ClinicalTrials.gov

Study to Assess the Metabolic Impact of IRTA© and Patients Satisfaction in Type 1 Diabetic Patients, Treated by Either Insulin Pump or Multiple Daily Insulin Injections, and Using Freestyle Libre®, a Real-time Continuous Glucose Monitoring

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

March 3, 2022

Study Completion Date

March 3, 2022

Conditions
Type 1 Diabetes
Interventions
OTHER

A decision support software

Insulin pump Continuous glucose monitoring

Trial Locations (1)

35033

CHU de Rennes, Rennes

All Listed Sponsors
lead

Rennes University Hospital

OTHER

NCT04211220 - Study to Assess the Metabolic Impact of IRTA© and Patients Satisfaction in Type 1 Diabetic Patients, Treated by Either Insulin Pump or Multiple Daily Insulin Injections, and Using Freestyle Libre®, a Real-time Continuous Glucose Monitoring | Biotech Hunter | Biotech Hunter